Device Trial Radar · NCT03857919
TearCare System to Treat Dry Eye Disease
Last checked: Nov 20, 2026Latest source record: Oct 1, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
235
Actual
Start
Mar 3, 2019
Primary completion
Feb 17, 2020
Study completion Dec 18, 2020
Sponsor
- Lead sponsor
- Sight Sciences, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Feb 28, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
In this study, the TearCare System will be compared with the LipiFlow Thermal Pulsation System in patients with dry eye disease. The objective is to demonstrate that the TearCare System is safe and effective in relieving the signs and symptoms of dry eye disease.
Conditions
- Dry Eye
- Meibomian Gland Dysfunction
Interventions
TearCareDevice
The TearCare SmartLids will be applied to the external surface of each eyelid. The TearCare System will be turned on and heat will be delivered to the eyelids for 15 minutes. Immediately following the thermal portion of the procedure, the SmartLids will be removed and the doctor will manually express the meibomian glands.
LipiFlowDevice
The LipiFlow activators will be placed between the inner eyelid and the corneal surface of each eye. The LipiFlow System will be turned on and heat and pressure will be delivered to each eyelid for 12 minutes.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Tear Break-Up Time (TBUT) From BaselineTime frame: 1 month
1 more outcomes with a free account
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
Schwartz Laser Eye Center
Scottsdale, Arizona
9 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.